ROSLEA SURGERY — All Prescriptions & Medications — Page 2
Practice Code: P81083 | PRESTON, PR5 6PE
Showing results 51-100 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 793 | 9,660 | £7.6K | +19.4% ▲ | |
| Buprenorphine | 780 | 3,254 | £14.6K | +112.9% ▲ |
| Isosorbide mononitrate | 773 | 30.8K | £8.1K | +17.0% ▲ |
| Hydroxocobalamin | 755 | 795 | £1.7K | +56.9% ▲ |
| Latanoprost | 755 | 22.0K | £6.4K | +55.5% ▲ |
| Doxycycline hyclate | 746 | 8,026 | £789 | +45.5% ▲ |
| Montelukast | 726 | 22.6K | £1.7K | +6.0% ▲ |
| Esomeprazole | 700 | 30.7K | £2.1K | +73.0% ▲ |
| Doxazosin mesilate | 697 | 34.5K | £1.9K | -34.7% ▼ |
| Senna | 677 | 41.1K | £944 | +12.5% ▲ |
| Ezetimibe | 676 | 21.7K | £3.7K | -5.0% ▼ |
| Rosuvastatin calcium | 671 | 23.2K | £961 | -25.2% ▼ |
| Atenolol | 624 | 29.9K | £652 | +3.5% ▲ |
| Ibuprofen | 624 | 71.5K | £3.3K | +22.7% ▲ |
| Budesonide | 610 | 846 | £18.2K | +12.6% ▲ |
| Lamotrigine | 599 | 36.9K | £6.7K | +1.4% vs avg |
| Empagliflozin | 596 | 18.6K | £23.1K | -4.8% ▼ |
| Gliclazide | 592 | 31.1K | £1.0K | -30.4% ▼ |
| Warfarin sodium | 583 | 34.8K | £1.2K | +23.6% ▲ |
| Carbocisteine | 580 | 79.2K | £1.9K | +8.6% ▲ |
| Betamethasone valerate | 580 | 46.6K | £2.9K | +50.6% ▲ |
| Codeine phosphate | 572 | 50.5K | £1.7K | -20.4% ▼ |
| Flucloxacillin sodium | 572 | 24.4K | £1.3K | +27.2% ▲ |
| Hydrocortisone | 570 | 15.6K | £2.8K | +27.1% ▲ |
| Glucose blood testing reagents | 569 | 47.2K | £7.5K | -27.9% ▼ |
| Nitrofurantoin | 556 | 6,608 | £3.8K | +16.5% ▲ |
| Alginic acid compound preparations | 551 | 302.6K | £4.4K | -5.9% ▼ |
| Thiamine hydrochloride | 526 | 31.9K | £810 | -0.2% vs avg |
| Spironolactone | 517 | 16.3K | £1.4K | -4.1% ▼ |
| Levetiracetam | 507 | 54.8K | £3.6K | +10.7% ▲ |
| Sodium valproate | 506 | 102.8K | £9.1K | +59.1% ▲ |
| 504 | 1,020 | £35.4K | -7.5% ▼ | |
| Sildenafil (Erectile Dysfunction) | 495 | 4,469 | £623 | -1.8% vs avg |
| Ferrous fumarate | 482 | 32.7K | £1.1K | -33.5% ▼ |
| Venlafaxine | 477 | 24.1K | £5.7K | -43.5% ▼ |
| Rivaroxaban | 474 | 17.2K | £11.1K | -22.5% ▼ |
| 471 | 5,291 | £938 | +88.8% ▲ | |
| Famotidine | 470 | 20.7K | £11.8K | -3.7% ▼ |
| Lactulose | 469 | 265.6K | £2.5K | +42.5% ▲ |
| Mometasone furoate | 461 | 512 | £3.9K | +14.8% ▲ |
| Ferrous sulfate | 459 | 24.6K | £871 | -10.7% ▼ |
| Finasteride | 457 | 16.9K | £593 | -30.2% ▼ |
| Lisinopril | 455 | 17.1K | £377 | -58.5% ▼ |
| Mirabegron | 453 | 15.8K | £14.6K | +12.8% ▲ |
| Diazepam | 449 | 12.0K | £283 | -9.9% ▼ |
| Progesterone | 448 | 39.7K | £8.5K | +7.0% ▲ |
| Ranolazine | 442 | 29.3K | £5.4K | +160.1% ▲ |
| Memantine hydrochloride | 434 | 14.2K | £1.8K | +31.4% ▲ |
| Sumatriptan succinate | 416 | 3,986 | £2.6K | +17.5% ▲ |
| Desogestrel | 408 | 70.1K | £2.1K | +2.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.